There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To develop RNA splicing biomarkers of disease severity and therapeutic response in
myotonic dystrophy type 1 (DM1) and type 2 (DM2).
[1
]
Department of Neurology, University of Rochester Medical Center, Rochester, NY; Center
for Neural Development and Disease, University of Rochester Medical Center, Rochester,
NY.